“showed a trend”

Multivariate analysis showed a trend for GLIS1 expression as an independent indicator for OS (HR = 0.157, p = 0.092) ( Table 4 ).

Quantification of RNAscope showed a trend towards increased number of Ghsr ( p = 0.0922), but not Cartpt ( p = 0.4598), or Slc17a6 ( vGlut2; p = 0.2668) expressing cells in female mice, compared to male counterparts (Fig. 4D ).

Meanwhile, among patients with [ALB] serum >3.77 g/dl, the NCOA3 high or TM4SF5 high /NCOA3 high groups showed significantly poorer clinical outcomes compared with those of the TM4SF5 low /COA3 low group, and the TM4SF5 high group showed a trend toward a poor clinical outcome (nonsignificant, P = 0.0925; Fig. 8c ).

Among the indices, CAR showed a trend toward a difference between the two groups (P=0.0926); however, NLR and PNI did not show significant differences.

Of note though, the behavioral score of mice under the jet lag procedure showed a trend toward a delayed development of the disease (ANOVA main effect of condition, p = 0.0927).

Regarding surgery modality, patients with CRM involvement showed a trend toward having undergone laparoscopic surgery ( p = 0.093) or D2 lymph node dissection ( p = 0.053) compared with patients without CRM involvement.

Additionally, citrate synthase (CS) activity, an indicator of mitochondrial density, showed a trend towards increased activity in the HFD + OS-1010 group compared to the HFD group ( P = 0.093, Fig. 4 e).

2C) showed a trend toward higher circulating exDNA in the AngII model compared to the EPPE model (1.83 ± 0.652 vs. 0.536 ± 0.078; p = 0.093).

Employment status showed a trend toward lower odds of distress among unemployed women (aOR = 0.567; 95% CI: 0.292–1.098; p = 0.093), although this did not reach statistical significance.

6.45 ng/mL, p = 0.0313) levels were significantly higher in the Rupture group, whereas NGAL showed a trend without statistical significance (59.03 vs. 53.80 ng/mL, p = 0.093).

After propensity score matching, PCI + group patients with colorectal cancer had a significantly better prognosis (log-rank test, P = 0.043), while those with gastric cancer showed a trend toward improvement (log-rank test, P = 0.093) despite the relatively small number of patients (n = 157 and n = 106, respectively) (Fig. 3 ).

The fraction of EBNA1 seropositive samples was slightly higher in the PCS group (45/48) versus the CC cohort (40/48; Fisher's exact test p = 0.1986) and the overall signals showed a trend towards higher signals in the PCS versus the CC samples ( p = 0.093; Mann–Whitney U test; Figure 2A ).

The high vinegar intake group showed a trend toward longer PFS: the median PFS was 492 days in patients consuming ≥0.05 g compared with 151 days in those consuming less (P = 0.093) ( Figure 7 ).

Higher AF-PRS, as a continuous variable ( Table 2 ), showed a trend toward an association with increased dementia risk at the 5 × 10 −8 (hazard ratio (HR) 1.11, 95% CI 0.98–1.26, P = 0.093), 1 × 10 −5 (HR 1.12, 95% CI 0.99–1.27, P = 0.071) and 1 × 10 −3 (HR 1.12, 95% CI 0.99–1.28, P = 0.071) thresholds.

Patients harboring both vimentin and PD-L1 negative expression (<1%) showed a trend towards better survival than those with ≥1% expression (HR=2.31; 95% CI: 0.87-6.17, P =0.093).

Fisher’s exact test on adequate samples showed a trend toward association ( p = 0.093), though this did not reach statistical significance due to the limited number of mutation-positive cases.

Patients who experienced CVAE showed a trend towards a higher prevalence of preexisting arterial hypertension compared to patients who did not experience a CVAE (53 vs. 35%, p = 0.093) whereas no differences were observed in age, sex, cardiovascular risk factors, and other preexisting cardiovascular comorbidities (Table 1 ).

Driving HR showed a trend for increment as compared to day time mean HR, from 85 ± 5.6 to 89.8 ± 5.6 beats/min (by 7%) ( P = 0.093).

Resting fecal bacterial family SEI on LFOD and HFOD did not substantially differ but showed a trend for higher diversity on HFOD ( p = 0.093, d = 0.76).

Moreover, the integrated PET/CT model significantly outperformed the PET-only model (DeLong test, p < 0.05) and showed a trend toward better performance compared with the CT-only model (DeLong test, p = 0.093).

Longer maternal viremia duration showed a trend toward increased ventral contact duration ( p = 0.093) but was not associated with approach behavior ( p = 0.367) (Table S11 ).

The interaction between time and eating disorder risk showed a trend toward significance at T3 ( p = .093) and T4 ( p = .053).

Among biomechanical factors, more medial COP correlated to greater average ankle eversion (R=0.61, p =0.002) and showed a trend for association with greater internal tibial rotation (R=-0.36, p =0.093).

Moreover, YW showed a trend for lower discriminatory ability for sarcopenia diagnosis (AUC: 0.515 vs. 0.683; p=0.093) and low ALMI (AUC: 0.568 vs. 0.726; p=0.054) in high WC compared with low WC, due to lower sensitivity (45.8% vs. 76.2%) for sarcopenia diagnosis and lower specificity (43.4% vs. 68.2%) for low ALMI.

HDR-iBT D 98% ( p = 0.029) and showed a trend for SBRT DIBH ( p = 0.093).